235 related articles for article (PubMed ID: 18465671)
1. Global Generic Medicines--Health Network Communications' Second Annual Summit.
Burck B
IDrugs; 2008 May; 11(5):328-30. PubMed ID: 18465671
[No Abstract] [Full Text] [Related]
2. The danger of in-kind drug donations to the Global Fund.
Baker BK; Ombaka E
Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
[No Abstract] [Full Text] [Related]
3. Controlling medicine prices in Sudan: the challenge of the recently established medicines regulatory authority.
Ali GK; Yahia Y
East Mediterr Health J; 2012 Aug; 18(8):811-20. PubMed ID: 23057369
[TBL] [Abstract][Full Text] [Related]
4. Trans-Pacific trade pact triggers fears over drug prices.
McCall C
Lancet; 2015 Jun; 385(9986):2450-1. PubMed ID: 26122057
[No Abstract] [Full Text] [Related]
5. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
Zain S
Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
[No Abstract] [Full Text] [Related]
6. Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.
Wang Z
Cornell Law Rev; 2014 Jul; 99(5):1227-58. PubMed ID: 25112001
[No Abstract] [Full Text] [Related]
7. The ongoing regulation of generic drugs.
Frank RG
N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
[No Abstract] [Full Text] [Related]
8. Globalization in the pharmaceutical industry, Part II.
Casadio Tarabusi C; Vickery G
Int J Health Serv; 1998; 28(2):281-303. PubMed ID: 9595345
[TBL] [Abstract][Full Text] [Related]
9. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
Baker BK
PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug prices in the US.
Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
[No Abstract] [Full Text] [Related]
11. Obama is urged to support India in supplying world with generic drugs.
Bagcchi S
BMJ; 2015 Feb; 350():h866. PubMed ID: 25701015
[No Abstract] [Full Text] [Related]
12. Creating a global health care company.
Bauman RP
J Bus Strategy; 1992; 13(2):4-7. PubMed ID: 10117143
[TBL] [Abstract][Full Text] [Related]
13. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
Teufel AT
J Contemp Health Law Policy; 2006; 22(2):383-408. PubMed ID: 17117702
[No Abstract] [Full Text] [Related]
14. Generic drugs get a life.
Cole RT; Saputo D
Mark Health Serv; 2003; 23(1):18-23. PubMed ID: 12645433
[No Abstract] [Full Text] [Related]
15. Demand-side policies to encourage the use of generic medicines: an overview.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
[TBL] [Abstract][Full Text] [Related]
16. Pharma 2020--An Economist Conference Shaping the Future of the Pharmaceuticals Industry.
Kibble A
IDrugs; 2008 May; 11(5):331-3. PubMed ID: 18465672
[No Abstract] [Full Text] [Related]
17. Retailing policies for generic medicines.
Narciso S
Int J Health Care Finance Econ; 2005 Jun; 5(2):165-90. PubMed ID: 15912315
[TBL] [Abstract][Full Text] [Related]
18. [Drugs in the European Union: the health-market complex].
Antoñanzas F; Rodríguez R; Sacristán JA; Illa R
Gac Sanit; 2005; 19(2):151-67. PubMed ID: 15860163
[TBL] [Abstract][Full Text] [Related]
19. The pharmaceutical situation in the Philippines.
Hartigan-Go K
Aust Health Rev; 2001; 24(2):25-31. PubMed ID: 11496467
[No Abstract] [Full Text] [Related]
20. Is India ready to lead the battle for fair access to medicines?
Lancet Oncology
Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
